GlaxoSmithKline in China: Challenges Faced
China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.
Aug 15, 2022 02:31 AM
ResearchConsumer Staples, Technology, Healthcare
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Gilead Reached USD 455 Mn Contract with Everest for Asian Rights
The company said it would use the money to fund additional dealmaking activities, clinical development of Calliditas Therapeutics-partnered kidney disease drug Nefecon in several Asia countries and other pipeline assets.
Yesterday 05:47 PM
Bennu Biotherapeutics Bags Over CNY 100 Mn in Angel+ Financing Round
Biotech Bennu Biotherapeutics, focusing on the R&D and conversion of cutting-edge technologies in the cell therapy, will continue to contribute to global innovative cellular therapies for oncology and autoimmune diseases with the fresh proceeds.
Aug 15, 2022 05:19 PM
Trautec Medical Raises Nearly CNY 200 Mn in Series A Financing Round
Trautec Medical, dedicated to developing and producing recombinant collagen-based biomaterials, will continue to focus on the innovation of biomaterials and strive to integrate resources from all sides.
Aug 12, 2022 06:12 PM
A Quick Look at The Semiconductor Industry: 60 Players of Key Fields [2/2]
Aug 15, 2022 05:01 PM
WIM2022: Transcripts of Fireside Chat: China Globalization [2/2]
Aug 12, 2022 03:00 PM